लोड हो रहा है...
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
AZD0530, an orally available Src inhibitor, demonstrated potent antimigratory and anti‐invasive effects in vitro, and inhibited metastasis in a murine model of bladder cancer. Antiproliferative activity of AZD0530 in vitro varied between cell lines (IC50 0.2 –>10μM). AZD0530 inhibited tumor growt...
में बचाया:
| में प्रकाशित: | Mol Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley and Sons Inc.
2009
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527863/ https://ncbi.nlm.nih.gov/pubmed/19393585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2009.01.002 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|